'Knock out the middlemen' is a campaign promise Donald Trump should keep

PBMs have a role to play in the system, but only if they actually negotiate lower costs and improve consumer access to drugs. Often, as in the case of the diabetes drug, they do the opposite.

Previous
Previous

Eagan’s Prime Therapeutics hit with $10.3M judgment in price-fixing case

Next
Next

PBM Prime Therapeutics to Pay $10 Million Antitrust Case Over Price-Fixing Scheme with Express Scripts, Inc.